Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc. - ROEverified

ACXP

Price:

$1.54

Market Cap:

$2.44M

Acurx Pharmaceuticals, Inc. functions as a clinical-stage biopharmaceutical firm focused on developing innovative antibiotic treatments for bacterial infections. The company's primary drug candidate is ibezapolstat, an antibiotic that utilizes a novel mechanism of action by targeting the polymerase IIIC enzyme. Ibezapolstat has successfully completed Phase II clinical trials for addressing Clostridium difficile infections. Additionally, Acurx is progressing with ACX-375C, an investigational therapeutic suitable for both oral and injectable administration. This compound is being developed to combat various gram-positive bacteria, including resistant strains such as methicillin-resistant Staph...[Read more]

Industry

Biotechnology

IPO Date

2021-06-25

Stock Exchange

NASDAQ

Ticker

ACXP

The ROE as of June 2026 (TTM) for Acurx Pharmaceuticals, Inc. (ACXP) is -153.93%

According to Acurx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -153.93%. This represents a change of 258.60% compared to the average of -42.93% of the last 4 quarters.

Acurx Pharmaceuticals, Inc. (ACXP) Historical ROE (quarterly & annually)

How has ACXP ROE performed in the past?

The mean historical ROE of Acurx Pharmaceuticals, Inc. over the last ten years is -559.73%. The current -153.93% ROE has changed -72.50% with respect to the historical average. Over the past ten years (40 quarters), ACXP's ROE was at its highest in in the March 2020 quarter at 0%. The ROE was at its lowest in in the December 2024 quarter at -452.23%.

Quarterly (TTM)
Annual

Average

-559.73%

Median

-170.27%

Minimum

-2292.74%

Maximum

-102.72%

Acurx Pharmaceuticals, Inc. (ACXP) ROE by Quarter and Year

Discovering the peaks and valleys of Acurx Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 633.96%

Maximum Annual ROE = -102.72%

Minimum Annual Increase = -93.40%

Minimum Annual ROE = -2292.74%

Quarterly (TTM)
Annual
YearROEChange
2025-151.21%-93.40%
2024-2292.74%633.96%
2023-312.38%88.96%
2022-165.31%60.94%
2021-102.72%-39.67%
2020-170.27%-76.46%

Acurx Pharmaceuticals, Inc. (ACXP) Average ROE

How has ACXP ROE performed in the past?

The current ROE of Acurx Pharmaceuticals, Inc. (ACXP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-918.77%

5-year avg

-604.87%

10-year avg

-559.73%

Acurx Pharmaceuticals, Inc. (ACXP) ROE vs. Peers

How is ACXP’s ROE compared to its peers?

Acurx Pharmaceuticals, Inc.’s ROE is greater than Aprea Therapeutics, Inc. (-59.54%), greater than Adial Pharmaceuticals, Inc. (-162.83%), greater than BioCardia, Inc. (-5456.14%), greater than HCW Biologics Inc. (-102.39%), greater than Galecto, Inc. (-122.61%), greater than Creative Medical Technology Holdings, Inc. (-88.50%), greater than Kiora Pharmaceuticals, Inc. (-59.30%), greater than IN8bio, Inc. (-96.39%), greater than Aptevo Therapeutics Inc. (-198.50%), less than Brainstorm Cell Therapeutics Inc. (109.21%),

Build a custom stock screener for Acurx Pharmaceuticals, Inc. (ACXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acurx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acurx Pharmaceuticals, Inc. (ACXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acurx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Acurx Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Acurx Pharmaceuticals, Inc. (ACXP)?

What is the highest ROE for Acurx Pharmaceuticals, Inc. (ACXP)?

What is the 3-year average ROE for Acurx Pharmaceuticals, Inc. (ACXP)?

What is the 5-year average ROE for Acurx Pharmaceuticals, Inc. (ACXP)?

How does the current ROE for Acurx Pharmaceuticals, Inc. (ACXP) compare to its historical average?